Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene
North America is the largest consumption place, with a consumption market share nearly 61.5% in 2017. Following North America, Asia-Pacific and Europe is the second two largest consumption places with the consumption market share of 18% and 17%, respectively.
According to this study, over the next five years the Transforming Growth Factor Beta 1 market will register a 11.3% CAGR in terms of revenue, the global market size will reach US$ 1790 million by 2024, from US$ 1050 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Transforming Growth Factor Beta 1 business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Transforming Growth Factor Beta 1 market by product type, application, key manufacturers and key regions and countries.
This study considers the Transforming Growth Factor Beta 1 value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Pirfenidone
Galunisertib
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
IPF
Cancer
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche
Shionogi Ltd
Acceleron Pharma Inc
Genzyme Corp
Isarna Therapeutics GmbH
Scholar Rock
Sirnaomics Inc
Eli Lilly and Co
Formation Biologics Inc
Novartis AG
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Transforming Growth Factor Beta 1 consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Transforming Growth Factor Beta 1 market by identifying its various subsegments.
Focuses on the key global Transforming Growth Factor Beta 1 manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Transforming Growth Factor Beta 1 with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Transforming Growth Factor Beta 1 submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
2019-2024 Global Transforming Growth Factor Beta 1 Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Transforming Growth Factor Beta 1 Consumption 2014-2024
2.1.2 Transforming Growth Factor Beta 1 Consumption CAGR by Region
2.2 Transforming Growth Factor Beta 1 Segment by Type
2.2.1 Pirfenidone
2.2.2 Galunisertib
2.2.3 Others
2.3 Transforming Growth Factor Beta 1 Consumption by Type
2.3.1 Global Transforming Growth Factor Beta 1 Consumption Market Share by Type (2014-2019)
2.3.2 Global Transforming Growth Factor Beta 1 Revenue and Market Share by Type (2014-2019)
2.3.3 Global Transforming Growth Factor Beta 1 Sale Price by Type (2014-2019)
2.4 Transforming Growth Factor Beta 1 Segment by Application
2.4.1 IPF
2.4.2 Cancer
2.4.3 Others
2.5 Transforming Growth Factor Beta 1 Consumption by Application
2.5.1 Global Transforming Growth Factor Beta 1 Consumption Market Share by Application (2014-2019)
2.5.2 Global Transforming Growth Factor Beta 1 Value and Market Share by Application (2014-2019)
2.5.3 Global Transforming Growth Factor Beta 1 Sale Price by Application (2014-2019)
3 Global Transforming Growth Factor Beta 1 by Players
3.1 Global Transforming Growth Factor Beta 1 Sales Market Share by Players
3.1.1 Global Transforming Growth Factor Beta 1 Sales by Players (2017-2019)
3.1.2 Global Transforming Growth Factor Beta 1 Sales Market Share by Players (2017-2019)
3.2 Global Transforming Growth Factor Beta 1 Revenue Market Share by Players
3.2.1 Global Transforming Growth Factor Beta 1 Revenue by Players (2017-2019)
3.2.2 Global Transforming Growth Factor Beta 1 Revenue Market Share by Players (2017-2019)
3.3 Global Transforming Growth Factor Beta 1 Sale Price by Players
3.4 Global Transforming Growth Factor Beta 1 Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Transforming Growth Factor Beta 1 Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Transforming Growth Factor Beta 1 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Transforming Growth Factor Beta 1 by Regions
4.1 Transforming Growth Factor Beta 1 by Regions
4.1.1 Global Transforming Growth Factor Beta 1 Consumption by Regions
4.1.2 Global Transforming Growth Factor Beta 1 Value by Regions
4.2 Americas Transforming Growth Factor Beta 1 Consumption Growth
4.3 APAC Transforming Growth Factor Beta 1 Consumption Growth
4.4 Europe Transforming Growth Factor Beta 1 Consumption Growth
4.5 Middle East & Africa Transforming Growth Factor Beta 1 Consumption Growth
5 Americas
5.1 Americas Transforming Growth Factor Beta 1 Consumption by Countries
5.1.1 Americas Transforming Growth Factor Beta 1 Consumption by Countries (2014-2019)
5.1.2 Americas Transforming Growth Factor Beta 1 Value by Countries (2014-2019)
5.2 Americas Transforming Growth Factor Beta 1 Consumption by Type
5.3 Americas Transforming Growth Factor Beta 1 Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Transforming Growth Factor Beta 1 Consumption by Countries
6.1.1 APAC Transforming Growth Factor Beta 1 Consumption by Countries (2014-2019)
6.1.2 APAC Transforming Growth Factor Beta 1 Value by Countries (2014-2019)
6.2 APAC Transforming Growth Factor Beta 1 Consumption by Type
6.3 APAC Transforming Growth Factor Beta 1 Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Transforming Growth Factor Beta 1 by Countries
7.1.1 Europe Transforming Growth Factor Beta 1 Consumption by Countries (2014-2019)
7.1.2 Europe Transforming Growth Factor Beta 1 Value by Countries (2014-2019)
7.2 Europe Transforming Growth Factor Beta 1 Consumption by Type
7.3 Europe Transforming Growth Factor Beta 1 Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Transforming Growth Factor Beta 1 by Countries
8.1.1 Middle East & Africa Transforming Growth Factor Beta 1 Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Transforming Growth Factor Beta 1 Value by Countries (2014-2019)
8.2 Middle East & Africa Transforming Growth Factor Beta 1 Consumption by Type
8.3 Middle East & Africa Transforming Growth Factor Beta 1 Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Transforming Growth Factor Beta 1 Distributors
10.3 Transforming Growth Factor Beta 1 Customer
11 Global Transforming Growth Factor Beta 1 Market Forecast
11.1 Global Transforming Growth Factor Beta 1 Consumption Forecast (2019-2024)
11.2 Global Transforming Growth Factor Beta 1 Forecast by Regions
11.2.1 Global Transforming Growth Factor Beta 1 Forecast by Regions (2019-2024)
11.2.2 Global Transforming Growth Factor Beta 1 Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Transforming Growth Factor Beta 1 Forecast by Type
11.8 Global Transforming Growth Factor Beta 1 Forecast by Application
12 Key Players Analysis
12.1 Roche
12.1.1 Company Details
12.1.2 Transforming Growth Factor Beta 1 Product Offered
12.1.3 Roche Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Roche News
12.2 Shionogi Ltd
12.2.1 Company Details
12.2.2 Transforming Growth Factor Beta 1 Product Offered
12.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Shionogi Ltd News
12.3 Acceleron Pharma Inc
12.3.1 Company Details
12.3.2 Transforming Growth Factor Beta 1 Product Offered
12.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Acceleron Pharma Inc News
12.4 Genzyme Corp
12.4.1 Company Details
12.4.2 Transforming Growth Factor Beta 1 Product Offered
12.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Genzyme Corp News
12.5 Isarna Therapeutics GmbH
12.5.1 Company Details
12.5.2 Transforming Growth Factor Beta 1 Product Offered
12.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Isarna Therapeutics GmbH News
12.6 Scholar Rock
12.6.1 Company Details
12.6.2 Transforming Growth Factor Beta 1 Product Offered
12.6.3 Scholar Rock Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Scholar Rock News
12.7 Sirnaomics Inc
12.7.1 Company Details
12.7.2 Transforming Growth Factor Beta 1 Product Offered
12.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Sirnaomics Inc News
12.8 Eli Lilly and Co
12.8.1 Company Details
12.8.2 Transforming Growth Factor Beta 1 Product Offered
12.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Eli Lilly and Co News
12.9 Formation Biologics Inc
12.9.1 Company Details
12.9.2 Transforming Growth Factor Beta 1 Product Offered
12.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Formation Biologics Inc News
12.10 Novartis AG
12.10.1 Company Details
12.10.2 Transforming Growth Factor Beta 1 Product Offered
12.10.3 Novartis AG Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Novartis AG News
13 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Transforming Growth Factor Beta 1
Table Product Specifications of Transforming Growth Factor Beta 1
Figure Transforming Growth Factor Beta 1 R